Who are we?
For 17 years we have supported basic research and knowledge generation in different institutions in the city of Medellín.
In 2019, with the interest of migrating towards proprietary and collaborative research with an applied science approach, Grupo Célula was born.
In 2020, we formalized the provision of laboratory services for human clinical research under national and international Good Clinical Practice standards.
Our research group is fostered by the desire to establish a transversal work through the intelligent management of health information in its different areas of study, ranging from the macro (tissues) to the minimum (DNA), being the cell the point of convergence.
We are recognized by MinCiencias as a research, technological development or innovation group of the National System of Science, Technology and Innovation - SNCTI, according to the last call (2021).
We are formed by an interdisciplinary team, oriented to seek solutions to the problems of daily work in diagnostic medicine and meet the needs of the company, our allies (clinical research centers, educational institutions, pharmaceutical and food industry, among others) and society.
We focus on applied research, proprietary or collaborative, in the lines of research:
- Molecular diagnostics
- Diagnostic medicine
- Data analytics.
All with application to the areas of Microbiology, Hematology, Pathology, Oncology, Endocrinology and Laboratory Medicine, among others.
Laboratory of clinical research centers.
We provide laboratory services for clinical research in humans under the standards of Good Clinical Practices, according to Resolution 2378 of June 27, 2008 of the Ministry of Social Protection of Colombia.
To this end, our laboratory, medical and scientific personnel are certified in good clinical practices by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH) of the U.S. Department of Health and Human Services.
What are we aiming at?
- Generate and manage applied scientific research, development and innovation projects, brought to the current needs, that allow obtaining new products, processes and services, or improvements in the current ones, that facilitate life and allow the continuous improvement of medicine in favor of results.
- Generate and manage strategic alliances with clinical research centers, educational institutions and companies in the pharmaceutical and food industry, through the execution of projects aimed at the application of scientific knowledge, development and/or innovation, which add value to the company, our allies and human life.
- To provide laboratory and research services in specialized diagnostic medicine, using updated and quality processes and technology, and under the standards of Good Clinical Practices, to ensure accurate results that meet the needs of our partners and the environment.
- Disseminate research results in specialized journals and/or scientific events at national and international level.
- To support the training of highly qualified human talent in undergraduate and graduate programs related to diagnostic medicine.
Our partners
Our publications
- Evaluation of new Toxocara canis chimeric antigens as an alternative to conventional TES-Ag for anti-Toxocara antibodies detection.
Original article. 2022.
Link: https://doi.org/10.1016/j.heliyon.2022.e11144
- Myeloproliferative Syndrome With Eosinophilia Associated With Translocation t(8; 13) and T-cell Lymphoblastic Lymphoma: A Case Report and Review of the Literature.
Case report. 2022.
- The importance of metrological traceability in diagnostic medicine.
Editorial. 2022.
Link: https://doi.org/10.36384/01232576.569
- Prostate Health Index (phi).
ABC of the laboratory. 2022.
Link: https://doi.org/10.36384/01232576.563
- Bacterial diversity analysis of freshwater sources for human use in rural areas of the tropical Andean region of Colombia.
Original article. 2022.
Link: https://doi.org/10.22354/in.v26i1.988
- The Paris System "Atypical Urothelial Cells" Category: Can the current criteria be improved?
Original article. 2021.
Link: https://doi.org/10.1016/j.jasc.2020.04.015
- Microbiological diagnosis in bronchoalveolar lavage. Literature review.
Revision. 2021.
Link: https://doi.org/10.36384/01232576.523
- Bronchoalveolar lavage and diagnosis of lower respiratory diseases.
Editorial. 2021.
Link: https://doi.org/10.36384/01232576.522
- Hemophilia A: an orphan disease.
Revision. 2021.
Link: https://doi. org/10.36384/01232576.452
- Evaluation of thyroid nodules with rapid on-site cytologic interpretation (ROSE).
Revision. 2021.
Link: https ://doi.org/10.36384/01232576.450
- Past, present and future in the study of thyroid nodules: role of cytology and molecular testing.
Editorial. 2021.
Link: https ://doi.org/10.36384/01232576.448
- Detection and genotyping of high-risk human papillomavirus by multiplex real-time PCR (RT-PCR HPV AR).
ABC of the laboratory. 2021.
Link: https://doi.org/10.36384/01232576.439
- Human papillomavirus (HPV) and cancer.
Revision. 2021.
Link: https://doi.org/10.36384/01232576.431
- Molecular laboratory in human papillomavirus (HPV) and cancer.
Editorial. 2021.
Link: https://doi.org/10.36384/01232576.430
- Silver nanoparticles functionalized in situ with D-limonene: effect on antibacterial activity.
Original article. 2020.
Link: https://doi.org/10.18273/revion.v33n1-2020008
- Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome With IgG Kappa/IgG Lambda Biclonal Gammopathy: A Rare Presentation of a Rare Disease.
Case report. 2020.
- COVID-19 IgM/IgG antibodies by immunochromatographic assay (rapid test).
ABC of the Laboratory. 2020.
Link: https://doi.org/10.36384/01232576.302
- Platelet function tests by the PFA-200 system.
ABC of the Laboratory. 2020.
Link: https://doi.org/10.36384/01232576.215
- History of thyroid function tests.
Editorial. 2020.
Link: https://doi.org/10.36384/01232576.208
- Medicine & Laboratory: a continuous challenge.
Editorial. 2020.
Link: https://doi.org/10.36384/01232576.9
Our projects
1. Evaluation of platelet function according to the conditions of transport and preservation of patient samples from Laboratorio Clínico Hematológico, Medellín 2021.
Own project. 2019-2022.
2. Characterization of the susceptibility pattern of Helicobacter pylori to six antibiotics in strains isolated from patients with gastroduodenal diseases from eastern Antioquia, Medellin and Apartado between 2015-2019.
Project in collaboration with the Bacteria and Cancer Group, Universidad de Antioquia. 2018-2022.
3. Modifications in muscle ultrasound, physical capacities, blood tests and anthropometry in university students after an exercise protocol for health.
Project in collaboration with the Research Group on Physical Activity and Health, Politécnico Colombiano Jaime Isaza Cadavid. 2018-2020.
4. Platelet activation persists after treatment in patients with acute P. vivax infection.
Project in collaboration with the Malaria Group, University of Antioquia. 2017-2020.
Contact us
For more information about the Cell Group visit our GrupLac: https://scienti.minciencias.gov.co/gruplac/jsp/visualiza/visualizagr.jsp?nro=00000000022235
For information on the provision of laboratory services for clinical research studies in humans, please contact us at [email protected] or through our customer service channels.
